The role of the gut microbiome in Alzheimer's disease

Katarzyna Łysiak; Anna Łysiak

doi:10.56782/pps.273

Published : 2024-11-21

Vol. 22 No. 4 (2024)

The role of the gut microbiome in Alzheimer's disease

Katarzyna Łysiak

Anna Łysiak

DOI: https://doi.org/10.56782/pps.273

Abstract

Introduction: Alzheimer's disease (AD) is the most common form of dementia, characterized by progressive loss of memory and cognitive function. Although the etiopathogenesis of this condition is not yet fully understood, in recent years there has been a growing body of research indicating an important link between the gut microbiome and brain health, including its involvement in the pathogenesis of AD. Aim of the article: The purpose of this article is to outline the role of the gut microbiome in the development and progression of AD, and to discuss potential therapeutic strategies resulting from a better understanding of this relationship. State of the Art: The gut microbiome, consisting of trillions of microorganisms, plays a key role in regulating immune response and neurological function through the gut-brain axis. Microbial imbalances in the gut, known as dysbiosis, can lead to chronic inflammation and increased intestinal permeability. Such conditions promote neuroinflammation, which is an important factor in the pathogenesis of AD. In addition, gut bacteria affect the production of metabolites, such as short-chain fatty acids (SCFAs), which exhibit neuroprotective properties. Conclusions: Understanding the role of the gut microbiome in Alzheimer's disease opens up new therapeutic possibilities. Probiotics, prebiotics and dietary interventions can help restore microbial balance, reduce inflammation and improve brain health. Research on the gut microbiome may provide key information to develop innovative strategies for AD prevention and treatment.

Keywords:

gut microbiome, Alzheimer's, brain-gut axis, neurogenesis

Similar Articles

Mateusz Sobczyk, Daria Żuraw, Paulina Oleksa, Kacper Jasiński, Mikołaj Porzak, Michał Dacka, SGLT2 inhibitors and their possible use in prevention and treatment of neurological diseases , Prospects in Pharmaceutical Sciences: Vol. 22 No. 1 (2024)
Katarzyna Herjan, Piotr Armański, Jakub Olszewski, Magdalena Sitnik, Maciej Bara, Positive impact of tranexamic acid in various medical settings , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
Sylwia Kraczkowska, Zofia Suchocka, Jan Pachecka, ELEVATED BLOOD LEVEL OF HOMOCYSTEINE AS INDICATOR OF HEALTH HAZARD , Prospects in Pharmaceutical Sciences: Vol. 3 No. 3 (2005)
Helena E. Makulska-Nowak, ALCOHOL VERSUS CANNABIS - COMPARISON OF RISK , Prospects in Pharmaceutical Sciences: Vol. 11 No. 6 (2013)
Martyna Z. Wróbel, Monika Marciniak, 5-HT1A RECEPTOR LIGANDS AS POTENTIAL ANTIDEPRESSANTS , Prospects in Pharmaceutical Sciences: Vol. 13 No. 5 (2015)
Diana Dolzhko, Natalia Melnyk, Aleksandra Kruk, Sebastian Granica, Jakub Piwowarski, Traditional use of polar extracts from lavender flowers – systematic review of literature data , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
Ewelina Flegiel, Magdalena Piotrowska, Magdalena Ptasznik, Aleksandra Baran, Justyna Lenart, Miłosz Podrażka, Joanna Mazurek, Hubert Stachowicz, Weronika Bartos, Monika Adamczyk, Review of the effects of sodium butyrate on obesity, inflammatory bowel disease, pregnancy and colorectal cancer , Prospects in Pharmaceutical Sciences: Vol. 22 No. 4 (2024)

You may also start an advanced similarity search for this article.

Details

References

Statistics

Authors

Download files

PDF (Język Polski)

Citation rules

Łysiak, K., & Łysiak, A. (2024). The role of the gut microbiome in Alzheimer’s disease. Prospects in Pharmaceutical Sciences, 22(4), 81–85. https://doi.org/10.56782/pps.273

Altmetric indicators

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

1. Tiwari, S.; Atluri, V.; Kaushik, A.; Yndart, A.; Nair, M. Alzheimer's disease: pathogenesis, diagnostics, and therapeutics. Int. J. Nanomed. 2019, 14, 5541-5554. DOI: 10.2147/IJN.S200490

2. Practical Medicine. Available online: https://www.mp.pl/pacjent/neurologia/choroby/151134,choroba-alzheimera. (accessed on 25.05.2024).

3. NEUROEXPERT Encyclopedia of Neurophysiology. Available online: https://neuroexpert.org/mikrobiota-jelit-a-choroba-alzheimera/ (accessed on 25.05.2024).

4. Grabrucker, S.; Marizzoni, M.; Silajdžić, E.; Lopizzo, N.; et al. Microbiota from Alzheimer's patients induce deficits in cognition and hippocampal neurogenesis. Brain 2023, 146, 4916-4934. DOI: 10.1093/brain/awad303

5. Angelucci, F.; Cechowa, K.; Amlerowa, J.; Horta, J. Antibiotics, gut microbiota, and Alzheimer’s disease. J. Neuroinflamm. 2019, 16, Art. No: 108. DOI: 10.1186/s12974-019-1494-4

6. Scheltens, P.; Strooper, B.D.; Kivipelto, M.; Holstege, H.; et al. Alzheimer’s disease. Lancet. 2021, 397, 1577–1590. DOI: 10.1016/S0140-6736(20)32205-4

7. Leszek, J. Alzheimer’s disease: current knowledge, therapeutic perspectives. Pol. Neurol. Rev. 2012, 8, 101-106.

8. Huttenhower, C.; Gevers, D.; Knight, R.; Abubucker, S.; Badger, J.H.; et al. Structure, Function and Diversity of the Healthy Human Microbiome. Nature. 2012, 486, 207–214. DOI: 10.1038/nature11234

9. Askarova S.; Umbayev, B.; Masoud, A. R.; Kaiyrlykyzy, A.; et al. The Links Between the Gut Microbiome, Aging, Modern Lifestyle and Alzheimer's Disease. Front. Cell. Infec. Microbiol. 2020, 10, Art. No: 104. DOI: 10.3389/fcimb.2020.00104

10. Rutayisire, E.; Huang, K.; Liu, Y.; et al. The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants’ life: a systematic review. BMC Gastroenterol. 2016, 16, Art. No: 86. DOI: 10.1186/s12876-016-0498-0

11. Oziom, J.; Budrewicz, S. The role of intestinal microbiota in the pathogenesis and course of selected diseases of the nervous system. Pol. Neurol. Rev. 2019, 15(1), 1–11. DOI: 10.5603/PPN.2019.0005

12. Barrett, E.; Ross, R.P.; O’Toole, P.W.; et al. γ-Aminobutyric acid production by culturable bacteria from the human intestine. J. Appl. Microbiol. 2012, 113, 411–417. DOI: 10.1111/j.1365-2672.2012.05344.x

13. Vogt, N.M.; Kerby, R.L.; Dill-McFarland, K.A.; et al. Gut microbiome alterations in Alzheimer’s disease. Sci. Rep. 2017, 7, Art. No. 13537. DOI: 10.1038/s41598-017-13601-y

14. Murray, E.R.; Kemp, M.; Nguyen, T.T. The Microbiota-Gut-Brain Axis in Alzheimer’s Disease: A Review of Taxonomic Alterations and Potential Avenues for Interventions. Arch. Clin. Neuropsychol. 2022, 37, 595–607. DOI: 10.1093/arclin/acac008

15. Ghosh, T.S.; Shanahan, F.; O'Toole, P.W. The gut microbiome as a modulator of healthy ageing. Nat. Rev. Gastroenterol. Hepatol. 2022, 19, 565-584. DOI: 10.1038/s41575-022-00605-x

16. Cryan, J.F.; O'Riordan, K.J.; Cowan, C.S.M.; et al. The Microbiota-Gut-Brain Axis. Physiol. Rev. 2019, 99, 1877-2013. DOI: 10.1152/physrev.00018.2018

17. Bonaz, B.; Bazin, T.; Pellissier, S. The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis. Front. Neurosci. 2018, 12, Art. No. 49 . DOI: 10.3389/fnins.2018.00049

18. Dinan, T.G.; Cryan, J.F. The Microbiome-Gut-Brain Axis in Health and Disease. Gastroenterol. Clin. North. Am. 2017, 46, 77–89. DOI: 10.1016/j.gtc.2016.09.007

19. Galland, L. The gut microbiome and the brain. J. Med. Food. 2014, 17, 1261–1272. DOI: 10.1089/jmf.2014.7000

20. Alam, R.; Abdolmaleky, H.M.; Zhou, J.R. Microbiome, inflammation, epigenetic alterations, and mental diseases. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2017, 174, 651–660. DOI: 10.1002/ajmg.b.32567

21. De Lucia, C.; Murphy, T.; Maruszak, A.; et al. Serum from Older Adults Increases Apoptosis and Molecular Aging Markers in Human Hippocampal Progenitor Cells. Aging Dis. 2021, 12, 2151-2172. DOI: 10.14336/AD.2021.0409

22. Kim, T.A.; Syty, M.D.; Wu, K.; Ge, S. Adult hippocampal neurogenesis and its impairment in Alzheimer's disease. Zool. Res. 2022, 43, 481-496. DOI: 10.24272/j.issn.2095-8137.2021.479

23. Wu, G.D.; Chen, J.; Hoffmann, C.; et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011, 334, 105–108. DOI: 10.1126/science.1208344

24. McGrattan, A.M.; McGuinness, B.; McKinley, M.C.; et al. Diet and Inflammation in Cognitive Ageing and Alzheimer’s Disease. Curr. Nutr. Rep. 2019, 8, 53–65. DOI: 10.1007/s13668-019-0271-4

25. Davis, C.; Bryan, J.; Hodgson, J.; Murphy, K. Definition of the Mediterranean Diet; a Literature Review. Nutrients. 2015, 7, 9139–9153. DOI: 10.3390/nu7115459

26. Institute of Microecology. Available online: https://instytut-mikroekologii.pl/dieta-i-mikrobiota-a-choroba-alzheimera/ (accessed 01.06.2024).

27. Mosconi, L.; Murray, J.; Tsui, W. H.; Li, Y.; et al. Mediterranean diet and magnetic resonance imaging-assessed brain atrophy in cognitively Normal individuals at risk for Alzheimer's disease. J. Prev. Alzheimers Dis. 2014, 1, 23-32.

28. Flanagan, E.; Müller. M.; Hornberger, M.; Vauzour, D. Impact of Flavonoids on Cellular and Molecular Mechanisms Underlying Age-Related Cognitive Decline and Neurodegeneration. Curr. Nutr. Rep. 2018, 7, 49-57. DOI: 10.1007/s13668-018-0226-1

29. Devassy, J.G.; Leng, S.; Gabbs, M.; et al. Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease. Adv. Nutr. 2016, 7, 905–916. DOI: 10.3945/an.116.012187

30. Morris, M.C.; Tangney, C.C.; Wang, Y.; Sacks, F.M.; et al. MIND diet associated with reduced incidence of Alzheimer's disease. Alzheimers Dement. 2015, 11, 1007-1014. DOI: 10.1016/j.jalz.2014.11.009

31. Minter, M.R.; Zhang, C.; Leone, V.; Ringus, D.L.; Zhang, X.; et al. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer's disease. Sci. Rep. 2016, 6, Art. No. 30028. DOI: 10.1038/srep30028

32. Kountouras, J.; Boziki, M.; Gavalas, E.; Zavos, C.; Grigoriadis, N.; Deretzi, G, et al. Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease. J. Neurol. 2009, 256, 758-67. DOI: 10.1007/s00415-009-5011-z

33. Janicka, N.; Świątek, M.; Kaczmarek-Zalewska, A.; Kotarba, M.; Karolczyk, P.; Jońca, B.; Karłowicz-Bodalska, K. Obiecujące zastosowania bakterii probiotycznych jako wsparcie terapii depresji, chorób neurodegeneracyjnych – przegląd najnowszych badań. [Promising uses of probiotic bacteria as support for therapy of depression, neurodegenerative diseases - review of recent studies] Farm. Pol. 2023, 79, Art. No: 2. DOI: 10.32383/farmpol/168696

34. Akbari, E.; Asemi, Z.; Daneshvar Kakhaki, R.; Bahmani, F.; Kouchaki, E.; Tamtaji, O. R.; Hamidi, G. A. and Salami, M. Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial. Front. Aging Neurosci. 2016, 8, Art. No: 256. DOI: 10.3389/fnagi.2016.00256.

Katarzyna Łysiak

kas.lysiak@gmail.com

Affiliation:

a:1:{s:5:"en_US";s:140:"Stefan Cardinal Wyszynski Provincial Specialist Hospital Independent Public Health Care Center in Lublin, al. Kraśnicka 100, 20-718 Lublin ";} Poland

Anna Łysiak

ann.lysiak@gmail.com
https://orcid.org/0009-0002-1157-9081

Affiliation:

Independent Public Clinical Hospital No. 4 in Lublin, ul. Doktora Kazimierza Jaczewskiego 8, 20-954 Lublin Poland

The role of the gut microbiome in Alzheimer's disease

Katarzyna Łysiak

Anna Łysiak

Abstract

Keywords:

Most read articles by the same author(s)

Similar Articles

Katarzyna Łysiak

Anna Łysiak